MARY PAUL to HIV Infections
This is a "connection" page, showing publications MARY PAUL has written about HIV Infections.
Connection Strength
3.202
-
A Case of in utero Transmission of Drug-resistant HIV in the United States. Pediatr Infect Dis J. 2022 01 01; 41(1):57-59.
Score: 0.303
-
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study. Lancet HIV. 2024 04; 11(4):e211-e221.
Score: 0.177
-
Lowering the risk of secondary HIV transmission: insights from HIV-positive youth and health care providers. Perspect Sex Reprod Health. 2010 Jun; 42(2):110-6.
Score: 0.136
-
Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy. J Allergy Clin Immunol. 2005 Apr; 115(4):848-55.
Score: 0.095
-
Morbidity and mortality during the first two years of life among uninfected children born to human immunodeficiency virus type 1-infected women: the women and infants transmission study. Pediatr Infect Dis J. 2005 Jan; 24(1):46-56.
Score: 0.093
-
The Leaky Preexposure Prophylaxis Cascade-Barriers and Facilitators to Preexposure Prophylaxis Uptake and Adherence Among Youth Experiencing Homelessness in the US South: A Mixed Methods Study. J Assoc Nurses AIDS Care. 2025 May-Jun 01; 36(3):271-283.
Score: 0.093
-
Results of a Randomized Wait-List Controlled Trial of CAYA: A Nurse Case Management HIV Prevention Intervention for Youth Experiencing Homelessness. AIDS Behav. 2025 Feb; 29(2):613-625.
Score: 0.092
-
Birth outcomes following bictegravir exposure during pregnancy. AIDS. 2025 Mar 15; 39(4):381-386.
Score: 0.092
-
Technology-Based Interventions, with a Stepped Care Approach, for Reducing Sexual Risk Behaviors and Increasing PrEP Initiation Among Transgender and Gender Expansive Youth and Young Adults. AIDS Behav. 2024 Dec; 28(12):3956-3969.
Score: 0.092
-
Enhancing routine HIV and STI testing among young men who have sex with men: primary outcomes of the get connected clinical randomized trial (ATN 139). BMC Public Health. 2024 04 17; 24(1):1072.
Score: 0.089
-
Lessons learned from conducting a community-based, nurse-led HIV prevention trial with youth experiencing homelessness: Pivots and pitfalls. Public Health Nurs. 2024 Jul-Aug; 41(4):806-814.
Score: 0.089
-
Standardized Definitions of In Utero Human Immunodeficiency Virus and Antiretroviral Drug Exposure Among Children. Clin Infect Dis. 2022 08 25; 75(2):347-355.
Score: 0.079
-
Forty-Eight Week Outcomes of a Site-Randomized Trial of Combined Cognitive Behavioral Therapy and Medication Management Algorithm for Treatment of Depression Among Youth With HIV in the United States. J Acquir Immune Defic Syndr. 2022 11 01; 91(3):296-304.
Score: 0.079
-
Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s. J Acquir Immune Defic Syndr. 2022 07 01; 90(3):343-350.
Score: 0.078
-
Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV. J Acquir Immune Defic Syndr. 2022 03 01; 89(3):303-309.
Score: 0.077
-
Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis. J Int AIDS Soc. 2022 03; 25(3):e25871.
Score: 0.077
-
High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus. Clin Infect Dis. 2021 10 20; 73(8):1388-1396.
Score: 0.075
-
Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children. J Allergy Clin Immunol. 2001 Aug; 108(2):258-64.
Score: 0.074
-
Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV. AIDS. 2021 07 01; 35(8):1191-1199.
Score: 0.073
-
Trends in post-partum viral load among women living with perinatal HIV infection in the USA: a prospective cohort study. Lancet HIV. 2020 03; 7(3):e184-e192.
Score: 0.066
-
Testing the Testers: Are Young Men Who Have Sex With Men Receiving Adequate HIV Testing and Counseling Services? J Acquir Immune Defic Syndr. 2019 12 01; 82 Suppl 2:S133-S141.
Score: 0.066
-
Nonadherence and unsuppressed viral load across adolescence among US youth with perinatally acquired HIV. AIDS. 2019 10 01; 33(12):1923-1934.
Score: 0.065
-
NK cells in treated HIV-infected children display altered phenotype and function. J Allergy Clin Immunol. 2019 07; 144(1):294-303.e13.
Score: 0.062
-
Pre-vaccination prevalence of anogenital and oral human papillomavirus in young HIV-infected men who have sex with men. Papillomavirus Res. 2019 06; 7:52-61.
Score: 0.062
-
The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis. PLoS Med. 2018 03; 15(3):e1002514.
Score: 0.058
-
Roles of Medication Responsibility, Executive and Adaptive Functioning in Adherence for Children and Adolescents With Perinatally Acquired HIV. Pediatr Infect Dis J. 2017 08; 36(8):751-757.
Score: 0.056
-
High self-reported non-adherence to antiretroviral therapy amongst adolescents living with HIV in Malawi: barriers and associated factors. J Int AIDS Soc. 2017 03 30; 20(1):21437.
Score: 0.055
-
Long-term pulmonary complications in perinatally HIV-infected youth. J Allergy Clin Immunol. 2017 Oct; 140(4):1101-1111.e7.
Score: 0.054
-
The immune system in vertical HIV infection: the immune response and disease progression. AIDS Res Hum Retroviruses. 1997 Jan 01; 13(1):1-4.
Score: 0.054
-
Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV. Clin Infect Dis. 2016 07 01; 63(1):133-137.
Score: 0.051
-
Legal Barriers to Adolescent Participation in Research About HIV and Other Sexually Transmitted Infections. Am J Public Health. 2016 Jan; 106(1):40-4.
Score: 0.050
-
Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection. Clin Infect Dis. 2016 Jan 01; 62(1):106-114.
Score: 0.049
-
Brief Report: Impact of Option B+ on the Infant PMTCT Cascade in Lilongwe, Malawi. J Acquir Immune Defic Syndr. 2015 Sep 01; 70(1):99-103.
Score: 0.049
-
Incidence of opportunistic illness before and after initiation of highly active antiretroviral therapy in children. Pediatr Infect Dis J. 2013 Oct; 32(10):1089-95.
Score: 0.043
-
Food insecurity, CD4 counts, and incomplete viral suppression among HIV+ patients from Texas Children's Hospital: a pilot study. AIDS Behav. 2013 Jun; 17(5):1683-7.
Score: 0.042
-
Low rates of mother-to-child HIV transmission in a routine programmatic setting in Lilongwe, Malawi. PLoS One. 2013; 8(5):e64979.
Score: 0.042
-
Sexual risk behavior among youth with perinatal HIV infection in the United States: predictors and implications for intervention development. Clin Infect Dis. 2013 Jan; 56(2):283-90.
Score: 0.040
-
Associations of cytokines, sleep patterns, and neurocognitive function in youth with HIV infection. Clin Immunol. 2012 Jul; 144(1):13-23.
Score: 0.039
-
Early immunological predictors of neurodevelopmental outcomes in HIV-infected children. Clin Infect Dis. 2009 Feb 01; 48(3):338-46.
Score: 0.031
-
Increased incidence of asthma in HIV-infected children treated with highly active antiretroviral therapy in the National Institutes of Health Women and Infants Transmission Study. J Allergy Clin Immunol. 2008 Jul; 122(1):159-65.
Score: 0.030
-
No association between antepartum serologic and genital tract evidence of herpes simplex virus-2 coinfection and perinatal HIV-1 transmission. Am J Obstet Gynecol. 2008 Apr; 198(4):399.e1-5.
Score: 0.029
-
Assessment of birth defects according to maternal therapy among infants in the Women and Infants Transmission Study. J Acquir Immune Defic Syndr. 2007 Mar 01; 44(3):299-305.
Score: 0.027
-
Relationship of pregnancy to human papillomavirus among human immunodeficiency virus-infected women. Obstet Gynecol. 2006 Oct; 108(4):953-60.
Score: 0.026
-
Gender differences in lymphocyte populations, plasma HIV RNA levels, and disease progression in a cohort of children born to women infected with HIV. Pediatrics. 2006 Jul; 118(1):146-55.
Score: 0.026
-
A 5-week-old HIV-1-exposed girl with failure to thrive and diffuse nodular pulmonary infiltrates. J Allergy Clin Immunol. 2004 Apr; 113(4):627-34.
Score: 0.022
-
Magnitude of IFN-gamma production in HIV-1-infected children is associated with virus suppression. J Allergy Clin Immunol. 2002 Aug; 110(2):255-61.
Score: 0.020
-
Objective measures of allergic disease in children with human immunodeficiency virus infection. J Allergy Clin Immunol. 1997 Nov; 100(5):707-11.
Score: 0.014
-
Characteristics of children surviving to 5 years of age or older with vertically acquired HIV infection. Pediatr AIDS HIV Infect. 1995 Dec; 6(6):350-3.
Score: 0.012